1. Home
  2. BIRK vs PCVX Comparison

BIRK vs PCVX Comparison

Compare BIRK & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIRK
  • PCVX
  • Stock Information
  • Founded
  • BIRK 1774
  • PCVX 2013
  • Country
  • BIRK United Kingdom
  • PCVX United States
  • Employees
  • BIRK N/A
  • PCVX N/A
  • Industry
  • BIRK
  • PCVX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BIRK
  • PCVX Health Care
  • Exchange
  • BIRK Nasdaq
  • PCVX Nasdaq
  • Market Cap
  • BIRK 9.4B
  • PCVX 14.7B
  • IPO Year
  • BIRK 2023
  • PCVX 2020
  • Fundamental
  • Price
  • BIRK $47.04
  • PCVX $106.97
  • Analyst Decision
  • BIRK Buy
  • PCVX Strong Buy
  • Analyst Count
  • BIRK 20
  • PCVX 7
  • Target Price
  • BIRK $60.79
  • PCVX $147.50
  • AVG Volume (30 Days)
  • BIRK 938.2K
  • PCVX 636.4K
  • Earning Date
  • BIRK 08-29-2024
  • PCVX 11-04-2024
  • Dividend Yield
  • BIRK N/A
  • PCVX N/A
  • EPS Growth
  • BIRK N/A
  • PCVX N/A
  • EPS
  • BIRK 0.63
  • PCVX N/A
  • Revenue
  • BIRK $1,846,639,880.00
  • PCVX N/A
  • Revenue This Year
  • BIRK $22.13
  • PCVX N/A
  • Revenue Next Year
  • BIRK $17.29
  • PCVX N/A
  • P/E Ratio
  • BIRK $75.71
  • PCVX N/A
  • Revenue Growth
  • BIRK 19.77
  • PCVX N/A
  • 52 Week Low
  • BIRK $37.98
  • PCVX $46.16
  • 52 Week High
  • BIRK $64.78
  • PCVX $121.06
  • Technical
  • Relative Strength Index (RSI)
  • BIRK 41.41
  • PCVX 39.76
  • Support Level
  • BIRK $46.84
  • PCVX $102.84
  • Resistance Level
  • BIRK $50.30
  • PCVX $115.56
  • Average True Range (ATR)
  • BIRK 1.15
  • PCVX 3.32
  • MACD
  • BIRK -0.19
  • PCVX -1.41
  • Stochastic Oscillator
  • BIRK 23.31
  • PCVX 21.55

About BIRK Birkenstock Holding plc

Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. The company operates in four operating segments based on its regional hubs: Americas, Europe and APMA (Asia Pacific, Middle East and Africa). The company sells its products through two main channels: business-to-business (B2B) and direct-to-consumer (DTC).

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.

Share on Social Networks: